Why Is Astera Labs Stock Underperforming?

Astera Labs (NASDAQ:ALAB) a company that specializes in semiconductor-based connectivity solutions for cloud and AI infrastructure, has declined by close to 36% year-to-date. The sell-off comes despite a strong recent financial performance, with Q1 2025 revenue up over 140% year-over-year and Q2 guidance of $170 million to $175 million, implying sequential growth of about 8.5%. So, what’s driving the pullback? For one, investor expectations appear to have been even higher, given the company’s lofty valuation and that disconnect has weighed on the stock. Additionally, recent insider selling may also have hurt sentiment.

Pivoting Toward AI Datacenters

The current weakness comes despite Astera’s growing relevance in the AI infrastructure space. Astera  started off as a supplier of high-speed connectivity solutions for CPUs such as PCIe retimers which are chips that boost and clean up data signals traveling over high-speed server connections. As demand for generative AI workloads surged, Astera pivoted from basic CPU interconnects to becoming an AI infrastructure enabler, expanding into AI-optimized optical modules and low-latency GPU interconnects.

This shift has positioned Astera as a player in the next-generation AI data center designs. While Intel, a key customer, is now struggling with a CPU slump, Astera has diversified its customer base and now works with multiple AI leaders including Nvidia. Notably, it is collaborating with Nvidia on NVLink Fusion, a next-gen interconnect designed for ultra-low-latency, memory-coherent GPU clustering. While ALAB stock has been volatile, if you seek upside with lower volatility than individual stocks, the Trefis High Quality portfolio presents an alternative – having outperformed the S&P 500 and generated returns exceeding 91% since its inception.

Strong Growth, High Valuation

Overall, Astera stock appears attractive but volatile – making it a tricky pick to buy at its current price of around $86, given that its current valuation is high. Going by what you pay per dollar of sales or profit, ALAB stock looks very expensive compared to the broader market. Astera Labs has a price-to-sales ratio of 33.8 compared to 3.1 for the S&P 500.  Additionally, the company’s price-to-free cash flow (P/FCF) ratio is 155.3 compared to 20.9 for S&P 500. And, it has a price-to-earnings (P/E) ratio of 400.8 vs. the benchmark’s 26.9.

However, the high multiples are partly justified by the company’s strong growth. Astera Labs’ Revenues have grown considerably over recent years, rising from around $80 million in 2022 to $396 million in 2024. That said, company’s profitability is a mixed bag. While Astera Labs’ Net Income was $41 million – indicating a poor Net Income Margin of 8.4% (vs. 11.6% for S&P 500), cash flows have been stronger. Astera Labs’ Operating Cash Flow (OCF) over this period was $144 million, pointing to a high OCF Margin of 29.3% (vs. 14.9% for S&P 500).

Not too happy about the volatile nature of ALAB stock? The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming the S&P 500 over the last 4-year period. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics

Invest with Trefis Market-Beating Portfolios
See all Trefis Price Estimates